secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001062993-26-001326
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma sells 4.47M shares for $3.85M under Yorkville SEPA through Mar 6, 2026
--------------------------------------------------------------------------------

- Total of 4,471,038 common shares sold under SEPA from Dec 2025 to Mar 2026 for aggregate $3,846,910.
- Largest single draw: 1,425,000 shares on Mar 6, 2026 for approx $640,110.
- Proceeds used partly to prepay outstanding debenture with Yorkville (previously disclosed in Sep 2025 8-K).
- Yorkville may resell shares under an effective registration statement; additional draws possible subject to SEPA conditions.
- Sales rely on Section 4(a)(2) exemption; Yorkville represented itself as an accredited investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/0001062993-26-001326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-001326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer